Consequently, GLP-1-RA can enhance the production of prostacyclin and nitric-oxide levels, and reduce angiotensin-II-type-1-receptor (AT1R) activation which may counteract the negative consequences of SARS-CoV-2-infection. The gene discussed is GLP1R; the disease is infection.